0 CHECKOUT

PRODUCT FILTERS

REGION

4
1
1

CATEGORIES

  • 7
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

5
8
8
15

PUBLISHED

0
3
4
15

PRODUCT TYPE

8
3
2
1
1

Search for: "Albany Molecular Research Inc-Deals & Alliances Report"

Albany Molecular Research, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

Published:  May 2015
Price:  From

Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies

“Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies” provides key data, information and analysis of the major trends and developments...

Published:  March 2011
Price:  From

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2015 (7th Edition)

The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the manufacturing...

Published:  December 2014
Price:  From

Early Toxicology: Markets and Approaches

Early toxicology testing is emerging as one of the mostsignificant areas of drug discovery. Toxicity is no longer something that can be left to the development stage, or just a small part of ADMET....

Published:  September 2012
Price:  From

Drug Discovery Technologies - Global Strategic Business Report

This report analyzes the worldwide markets for Drug Discovery Technologies in Millions of US$. The specific technology types analyzed are Bioanalytical Instruments, High Throughput Screening (HTS),...

Published:  October 2008
Price:  From

Outsourcing in Drug Discovery

The number and scope of drug discovery outsourcing agreements has grown rapidly over the past five years, and the pace will accelerate over the next five years. Outsourcing is now an essential part...

Published:  May 2003
Price:  From

Outsourcing in Drug Discovery, 2nd Edition

In the Spring of 2003, Kalorama published its first report on Outsourcing in Drug Discovery. Since then, so much has changed, the use of the term "2nd Edition" hardly seems appropriate. This new study...

Published:  January 2006
Price:  From

Industry Top Trends 2016: Health Care Dec 15

Abstract (Editor's Note: For the complete report with enhanced graphics, please see "Industry Top Trends 2016: Healthcare.") Ratings Outlook. The ratings outlook for health care services and equipment...

Published:  December 2015
Price: 

Biochips - Global Strategic Business Report

This report analyzes the worldwide markets for Biochips in US$ Million by the following Product Segments: DNA Chips, Protein Chips, and Lab Chips Annual estimates and forecasts are provided for the...

Published:  March 2012
Price:  From

Colon Cancers - Pipeline Review, Q1 2011

Colon Cancers - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Colon Cancers - Pipeline Review, Q1 2011', provides an overview of the Colon Cancers therapeutic pipeline. This report provides...

Published:  February 2011
Price:  From

Pharmaceutical Product Development, Inc. (PPDI) - Financial and Strategic SWOT Analysis Review

Pharmaceutical Product Development, Inc. (PPDI) - Financial and Strategic SWOT Analysis Review Summary Pharmaceutical Product Development, Inc. (PPD) is a contract research organization that offers...

Published:  September 2011
Price:  From

Evotec Aktiengesellschaft (EVT) - Financial and Strategic SWOT Analysis Review

Evotec Aktiengesellschaft (EVT) - Financial and Strategic SWOT Analysis Review Summary Evotec Aktiengesellschaft (Evotec) is a biopharmaceutical company engaged in discovering and developing novel...

Published:  May 2011
Price:  From

Leukemias - Pipeline Review, H1 2012

Leukemias – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Leukemias - Pipeline Review, H1 2012', provides an overview of the Leukemias therapeutic pipeline. This report provides information...

Published:  January 2012
Price:  From

Negative Outlooks On Global Corporates Exceed Positive Ones By The Widest Margin Since 2009, Says S&P Report Jan 16

Abstract MELBOURNE (Standard & Poor's) Jan. 12, 2016--The net outlook bias is a negative 11%, which is the worst level since the 2008-2009 financial crisis. That's according to a report by Standard...

Published:  January 2016
Price: 

Asia-Pacific And Latin America Amassed Debt At A Far Faster Pace Than Europe And North America, Says S&P Report Jan 16

Abstract MELBOURNE (Standard & Poor's) Jan. 14, 2016-Debt growth in Asia-Pacific and Latin America has outstripped the regions' GDP expansion during 2009-2015 at a far faster pace than that in Europe...

Published:  January 2016
Price: 
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group